Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: A prospective multicenter survey

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages

  Iba, Toshiaki ^a   Saito, Daizo ^b   Wada, Hideo ^c   Asakura, Hidesaku ^d  

^a JUNTENDO UNIVERSITY   (Japan)

^b National Defense Medical College   (Japan)

^c MIE UNIVERSITY   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

28 day all cause mortality rate; antithrombin; disseminated intravascular coagulation; heparin; postmarketing surveillance; severe sepsis

Indexed keywords

ANTITHROMBIN; HEPARIN;

ADOLESCENT; ADULT; AGED; BLEEDING; BODY WEIGHT; BRAIN HEMORRHAGE; DIGESTIVE SYSTEM HEMORRHAGE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; SOFT TISSUE BLEEDING;

EID: 84865252092     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.03.021     Document Type: Article

References (27)

1. K. Okajima, and M. Uchiba The anti-inflammatory properties of antithrombin III: new therapeutic implications Semin Thromb Hemost 24 1998 27 32
2. G. Dickneite, and B. Leithäuser Influence of antithrombin III on coagulation and inflammation in porcine septic shock Arterioscler Thromb Vasc Biol 19 1999 1566 1572
3. B.L. Warren, A. Eid, P. Singer, S.S. Pillay, P. Carl, and I. Novak Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial JAMA 286 2001 1869 1878
4. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, and R. Jaeschke Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
5. M. Levi Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient J Crit Care 16 2001 167 177
6. T. Iba, S. Gando, A. Murata, S. Kushimoto, D. Saitoh, and Y. Eguchi Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers J Trauma 63 2007 1093 1098
7. W. Ruf, C. Furlan-Freguia, and F. Niessen Vascular and dendritic cell coagulation signaling in sepsis progression J Thromb Haemost Suppl 1 2009 118 121
8. F. Baudo, T.M. Caimi, F. de Cataldo, A. Ravizza, S. Arlati, and G. Casella Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study Intensive Care Med 24 1998 336 342
9. T. Iba, and A. Kidokoro High-dose antithrombin therapy for sepsis J Trauma 49 2000 979 980
10. C.J. Wiedermann Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis Crit Care 10 2006 209 218
11. S. Gando, D. Saitoh, H. Ogura, T. Mayumi, K. Koseki, and T. Ikeda Disseminated intravascular coagulation (DIC) diagnosed based on the Japanese Association for Acute Medicine criteria is a dependent continuum to overt DIC in patients with sepsis Thromb Res 123 2009 715 718
12. S. Gando, D. Saitoh, H. Ogura, T. Mayumi, K. Koseki, and T. Ikeda Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey Crit Care Med 36 2008 145 150
13. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference, Definition for sepsis and organ failure and guidelines for the use innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
14. S. Gando, T. Iba, Y. Eguchi, Y. Ohtomo, K. Okamoto, and K. Koseki A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria Crit Care Med 34 2006 625 631
15. J.L. Vincent, A. de Mendonça, F. Cantraine, R. Moreno, J. Takala, and P.M. Suter Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study Crit Care Med 26 1998 1793 1800
16. S. Zeerleder, C.E. Hack, and W.A. Wuillemin Disseminated intravascular coagulation in sepsis Chest 128 2005 2864 2875
17. M. Jochum Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation Semin Hematol 32 1995 19 32
18. J.N. Hoffmann, C.J. Wiedermann, M. Juers, H. Ostermann, J. Kienast, and J. Briegel Benefit/risk profile of high-dosed antithrombin in patients with severe sepsis treated with and without concomitant heparin Thromb Hemost 95 2006 850 856
19. C.J. Wiedermann, J.N. Hoffmann, M. Juers, H. Ostermann, J. Kienast, and J. Briegel High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety Crit Care Med 34 2006 285 292
20. J. Kienast, M. Juers, C.J. Wiedermann, J.N. Hoffmann, H. Ostermann, and R. Strauss Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation J Thromb Haemost 4 2006 90 97
21. C.J. Wiedermann, and N.C. Kaneider A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis Blood Coagul Fibrinolysis 17 2006 521 526
22. M. Levi, C.H. Toh, J. Thachil, and H.G. Watson Guidelines for the diagnosis and management of disseminated intravascular coagulation Br J Haematol 145 2009 24 33
23. H. Wada, H. Asakura, K. Okamoto, T. Iba, T. Uchiyama, and K. Kawasugi Yoshioka AExpert consensus for the treatment of disseminated intravascular coagulation in Japan Thromb Res 125 2010 6 11
24. F.B. Taylor Jr. Toh CH, Hoots WK, Wada H, Levi M, Toward definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation Thromb Haemost 86 2001 1327 1330
25. K. Okabayashi, H. Wada, S. Ohta, H. Shiku, T. Nobori, and K. Maruyama Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit Am J Hematol 76 2004 225 229
26. M. Hayakawa, A. Sawamura, Y. Yanagida, M. Sugano, H. Hoshino, and S. Gando The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction Shock 30 2008 649 652
27. S. Gando, A. Sawamura, M. Hayakawa, H. Hoshino, and N. Kubota Oshiro A First day dynamic changes in antithrombin III activity after supplementation have a predictive value in critically ill patients Am J Hematol 81 2006 907 914